BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015; 7(5): 777-786 [PMID: 25914778 DOI: 10.4254/wjh.v7.i5.777]
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/777.htm
Number Citing Articles
1
Mario Rizzetto. Clinical Epidemiology of Chronic Liver Diseases2019; : 135 doi: 10.1007/978-3-319-94355-8_11
2
Anika Wranke, Heiner Wedemeyer. Antiviral therapy of hepatitis delta virus infection — progress and challenges towards cureCurrent Opinion in Virology 2016; 20: 112 doi: 10.1016/j.coviro.2016.10.002
3
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host2016; : 69 doi: 10.1128/9781555819040.ch3
4
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, Yujin Hoshida. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicineJournal of Hepatology 2018; 68(3): 526 doi: 10.1016/j.jhep.2017.09.016
5
Mahbobeh Hajiabdolbaghi, Zahra Abdiliae, Jaleh Bayani, Mehdi Qaempanah, Fereshteh Ghiasvand. Characteristics of Hepatitis B and D Co-infection: A Descriptive StudyHepatitis Monthly 2021; 21(1) doi: 10.5812/hepatmon.101630
6
J. -F. Blanc. Carcinome hépatocellulaire : nouveautés épidémiologiques et démarche diagnostiqueOncologie 2017; 19(5-6): 135 doi: 10.1007/s10269-017-2709-x
7
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C virusesCurrent Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
8
Ye Fan, Xiaofeng Qian, Chuanyong Zhang. U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese populationTumor Biology 2016; 37(11): 14629 doi: 10.1007/s13277-016-5352-z
9
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and DMicrobiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
10
Mario Rizzetto, Antonina Smedile, Alessia Ciancio. Clinical Virology2016; : 1409 doi: 10.1128/9781555819439.ch58
11
Patrizia Farci, Grazia Anna Niro, Fausto Zamboni, Giacomo Diaz. Hepatitis D Virus and Hepatocellular CarcinomaViruses 2021; 13(5): 830 doi: 10.3390/v13050830
12
Christopher Koh, Theo Heller, Jeffrey S. Glenn. Pathogenesis of and New Therapies for Hepatitis DGastroenterology 2019; 156(2): 461 doi: 10.1053/j.gastro.2018.09.058
13
Ben L Da, Theo Heller, Christopher Koh. Hepatitis D infection: from initial discovery to current investigational therapiesGastroenterology Report 2019; 7(4): 231 doi: 10.1093/gastro/goz023
14
Vincent Soriano, Antonio Aguilera. Hepatitis Delta Enters a New Therapeutic EraThe Journal of Infectious Diseases 2018; 217(8): 1173 doi: 10.1093/infdis/jix658
15
Vincent Soriano, Kenneth E. Sherman, Pablo Barreiro. Hepatitis delta and HIV infectionAIDS 2017; 31(7): 875 doi: 10.1097/QAD.0000000000001424
16
Yan Wang, Jeffrey S. Glenn, Mark A. Winters, Li-ping Shen, Ingrid Choong, Ya-lun Shi, Sheng-li Bi, Li-ying Ma, Hui Zeng, Fu-jie Zhang. A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detectionDiagnostic Microbiology and Infectious Disease 2018; 92(2): 112 doi: 10.1016/j.diagmicrobio.2018.05.016
17
Patrizia Farci, Grazia Anna Niro. Sherlock's Diseases of the Liver and Biliary System2018; : 421 doi: 10.1002/9781119237662.ch22
18
Frédéric Le Gal, Ségolène Brichler, Roland Sahli, Sylvie Chevret, Emmanuel Gordien. First international external quality assessment for hepatitis delta virus RNA quantification in plasmaHepatology 2016; 64(5): 1483 doi: 10.1002/hep.28772
19
Marc Ringehan, Jane A. McKeating, Ulrike Protzer. Viral hepatitis and liver cancerPhilosophical Transactions of the Royal Society B: Biological Sciences 2017; 372(1732): 20160274 doi: 10.1098/rstb.2016.0274
20
Tuvshinjargal Chimed, Tuvshingerel Sandagdorj, Ariana Znaor, Mathieu Laversanne, Badamsuren Tseveen, Purevsuren Genden, Freddie Bray. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008-12International Journal of Cancer 2017; 140(2): 302 doi: 10.1002/ijc.30463
21
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Ana Treviño, Laura Benítez-Gutiérrez, José M Peña, Pablo Barreiro. Delta hepatitis: new approaches to therapyFuture Virology 2016; 11(3): 197 doi: 10.2217/fvl-2015-0009
22
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancerBiological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
23
Christopher Koh, Ben L. Da, Jeffrey S. Glenn. HBV/HDV CoinfectionClinics in Liver Disease 2019; 23(3): 557 doi: 10.1016/j.cld.2019.04.005
24
Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantationHepatology International 2020; 14(5): 869 doi: 10.1007/s12072-020-10085-3
25
Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada, Amy C. H. Lee. Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse ModelACS Infectious Diseases 2019; 5(5): 738 doi: 10.1021/acsinfecdis.8b00192
26
Theo Heller, Christopher Koh, Jeffrey S. Glenn. Zakim and Boyer's Hepatology2018; : 501 doi: 10.1016/B978-0-323-37591-7.00034-3
27
Raffaella Romeo, Arnolfo Petruzziello, Eve Isabel Pecheur, Floriana Facchetti, Riccardo Perbellini, Enrico Galmozzi, Najeeb Ullah Khan, Lucia Di Capua, Rocco Sabatino, Gerardo Botti, Giovanna Loquercio. Hepatitis delta virus and hepatocellular carcinoma: an updateEpidemiology and Infection 2018; 146(13): 1612 doi: 10.1017/S0950268818001942
28
Lihua Wang, Zheng Zhu, Lei Han, Liqian Zhao, Jialei Weng, Hongbao Yang, Shijia Wu, Kaiyuan Chen, Liang Wu, Tongke Chen. A curcumin derivative, WZ35, suppresses hepatocellular cancer cell growthviadownregulating YAP-mediated autophagyFood & Function 2019; 10(6): 3748 doi: 10.1039/C8FO02448K
29
Caterina Sagnelli, Evangelista Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Laura Occhiello, Nicola Coppola. HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future ChallengesLife 2021; 11(2): 169 doi: 10.3390/life11020169
30
Haris Muhammad, Aniqa Tehreem, Muhammad Baraa Hammami, Peng-Sheng Ting, Ramzan Idilman, Ahmet Gurakar. Hepatitis D virus and liver transplantation: Indications and outcomesWorld Journal of Hepatology 2021; 13(3): 291-299 doi: 10.4254/wjh.v13.i3.291
31
Ricardo Flores, Robert A Owens, John Taylor. Pathogenesis by subviral agents: viroids and hepatitis delta virusCurrent Opinion in Virology 2016; 17: 87 doi: 10.1016/j.coviro.2016.01.022
32
Mianzhi Chen, Dan Du, Wen Zheng, Mingheng Liao, Lu Zhang, Ge Liang, Meng Gong. Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathioneS-transferase P1 and induces liver injury and hepatocarcinogenesisBiochemistry and Cell Biology 2019; 97(2): 130 doi: 10.1139/bcb-2017-0321
33
Parag Mahale, Peter Aka, Xiaohua Chen, Ruth M. Pfeiffer, Ping Liu, Sarah Groover, Maimuna Mendy, Ramou Njie, James J. Goedert, Gregory D. Kirk, Jeffrey S. Glenn, Thomas R. O'Brien. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The GambiaJournal of Viral Hepatitis 2019; 26(6): 738 doi: 10.1111/jvh.13065